BIOE
What one share of Bio Essence holds
Pharmaceutical Preparations
On January 27, 2016, the Company entered into a change of control whereby our controlling
Bio Essence’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.07 |
|---|---|
| Profit | $0.04 |
| Cash and investments | $0.00 |
| Debt | $0.00 |
| Book value | $0.04 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | $0.03 | −$0.02 | $0.00 | −$0.02 | — | −$0.05 |
| 2021 | $0.03 | −$0.02 | $0.00 | −$0.04 | — | −$0.07 |
| 2022 | $0.02 | −$0.02 | $0.00 | −$0.02 | — | −$0.10 |
| 2023 | $0.02 | −$0.03 | $0.00 | −$0.03 | — | −$0.04 |
| 2024 | $0.01 | −$0.03 | — | $0.02 | — | −$0.08 |
| 2025 | $0.05 | $0.02 | — | $0.04 | — | −$0.05 |